Buy Thymalin Research Peptide

Thymalin is a polypeptide complex preparation derived from calf thymus tissue, consisting of a heterogeneous mixture of low-molecular-weight peptide fractions with molecular weights ranging from approximately 1,000 to 10,000 Da. Unlike the single-entity compounds in this catalog, Thymalin represents a standardized multi-component peptide extract obtained through acid extraction and chromatographic fractionation of calf thymus tissue. The preparation contains multiple biologically active thymic peptide fractions, including components that have been individually characterized as T-cell maturation-associated signaling molecules. Thymalin was developed in the 1970s by Vladimir Khavinson and Vyacheslav Morozov at the Kirov Military Medical Academy in Leningrad, and has since been documented in the Russian bioregulation literature, including later work from the Saint Petersburg Institute of Bioregulation and Gerontology (founded 1992).

Thymalin’s heterogeneous composition has been the subject of many proteomic and chromatographic characterization studies. In vitro studies using the human THP-1 monocyte/macrophage cell-line model have examined Thymalin alongside other peptide preparations, reporting modulation of proliferative and inflammatory signaling pathways, including effects on MAPK-related phosphorylation events. In LPS-stimulated differentiated THP-1 macrophage preparations, the peptide panel was associated with reduced secretion of pro-inflammatory cytokines, consistent with the use of this system to characterise interactions between thymic peptide preparations and innate immune-cell inflammatory responses [1]. In vivo rodent studies have investigated Thymalin in immunological and gerontological research protocols, showing that long-term administration of a low-molecular-weight thymus factor modulated immune function parameters, reduced spontaneous tumor incidence, and extended lifespan in C3H/Sn mouse cohorts followed from adulthood to natural death, characterizing the thymic polypeptide preparation as an immunomodulatory and gerontological research agent across extended observation periods [2], making Thymalin a reference preparation in thymic peptide research examining immune cell modulation and gerontological endpoints in preclinical models.

Thymalin is produced to research-grade standards and independently verified by third-party HPLC and MS-UPLC analysis before dispatch. Vials are vacuum sealed and stored in a temperature controlled, monitored cold storage system. Certificates of Analysis are available to view and download directly on the product page.

Sold strictly for in vitro research purposes only. Not for human consumption. Intended for use by qualified researchers in laboratory settings only.

Scientific Review

Dr. Martina Rossi, PhD

Scientific Contributor and Reviewer

Reviewed for scientific accuracy, 11 August 2026

View credentials →